Tag: the war on (some) drugs

Congressional Committee Moves To Block Marijuana Rescheduling

A GOP-controlled House committee has unveiled a new spending bill that contains provisions to block the Justice Department from rescheduling marijuana. The legislation would also maintain a separate longstanding rider protecting state medical cannabis programs from federal interference—though with new language authorizing enhanced penalties for sales near schools and parks.

On Monday, the House Appropriations Committee released the text of the spending measure covering Commerce, Justice, Science, and Related Agencies (CJS). For the second time now, the base legislation contains language hostile to marijuana rescheduling efforts that remain ongoing.

Specifically, the bill would block the Justice Department from using its funds to reschedule or deschedule marijuana. Under the Biden administration, DOJ recommended moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), but that process has been delayed for months amid challenges from witnesses in the administrative hearings.

Here’s the text of the provision: 

“SEC. 607. None of the funds appropriated or other wise made available by this Act may be used to reschedule marijuana (as such term is defined in section 102 of the Controlled Substances Act (21 U.S.C. 802)) or to remove marijuana from the schedules established under section 202 of the Controlled Substances Act (21 U.S.C. 812).”

The language cleared committee as part of the last CJR spending bill, but it was not ultimately enacted into law. The new measure is scheduled for subcommittee action on Tuesday.

GOP senators have separately tried to block the administration from rescheduling cannabis as part of a standalone bill filed in 2023, but that proposal did not receive a hearing or vote.

Meanwhile, the Drug Enforcement Administration (DEA) recently notified an agency judge that the marijuana rescheduling process remains stalled under the Trump administration.

It’s been over six months since DEA Administrative Law Judge (ALJ) John Mulrooney temporarily paused hearings on a proposal to move cannabis to Schedule III. And in a joint report to the judge submitted earlier this month, DEA attorneys and rescheduling proponents said they’re still at an impasse.

To the relief of advocates, the latest CJS bill does continue to preserve a longstanding rider to prevent DOJ from using its funds to interfere in the implementation of state medical marijuana programs that has been part of federal law since 2014.

However, it stipulates that the Justice Department can still enforce a section of U.S. code that calls for increased penalties for distributing cannabis within 1,000 feet of an elementary school, vocational school, college, playground or public housing unit. That language was first included in the last version of the appropriations legislation.

Keep reading

Nerve pain medication gabapentin possibly tied to dementia, study says

A drug used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of dementia, a new study says.

Regular gabapentin use appeared to increase risk of dementia by 29% and mild cognitive impairment by 85%, researchers reported Thursday in the journal Regional Anesthesia & Pain Medicine.

What’s more, the risk was more than doubled in people normally considered too young to suffer from brain aging, those 18 to 64, results show.

“The findings of this study support the need for close monitoring in adult patients prescribed gabapentin to assess for potential cognitive decline,” wrote the research team led by Nafis Eghrari, a medical student at Case Western Reserve University in Cleveland.

“Moreover, this provides a foundation to further research whether gabapentin plays a causal role in the development of dementia and cognitive decline,” the researchers added.

Gabapentin has become increasingly popular for the treatment of chronic pain because it’s not nearly as addictive as opioids, researchers said in background notes.

But concerns have been growing that gabapentin might contribute to cognitive decline, since it works by suppressing communication between nerve cells, researchers said.

Keep reading

Psychedelic Retreats ‘Significantly Improved’ Mental Health For Military Veterans With PTSD And Depression, Study Finds

A new study of military veterans who attended psychedelics retreats finds that psilocybin and ayahuasca both yielded significant improvements in participants’ mental health, including reductions in symptoms of PTSD, depression and anxiety as well as improved sleep, quality of life and post-deployment reintegration.

The report, published in the journal Brain and Behavior, describes the research as “the first study to investigate psychedelic retreats as a holistic therapy for veterans’ mental health alongside community reintegration.”

“Psilocybin and ayahuasca retreats significantly improved veterans’ mental well-being, quality of life, PTSD, anxiety, depression, sleep, concussion, and post-deployment reintegration,” it says, adding that the retreats “could provide a treatment framework to aid veterans’ recovery by addressing psychological well-being, communal factors, and reintegration into civilian life.”

The study followed 55 veterans who self-enrolled in psychedelic retreats using psilocybin or ayahuasca following a program by Heroic Hearts Project, a nonprofit that connects veterans with psychedelic therapy in jurisdictions where it’s legal.

“For psilocybin, the substance was taken as a tea brewed from dried psilocybin mushrooms with individualized doses determined by the retreat staff between 1.5 and 3.5 g for Session 1 and between 3 and 5 g for Session 2,” the report says. “One gram boosters of psilocybin were offered one hour from the initial dose.”

Keep reading

THERE IT IS: Cannabis Farm Raided by ICE Donated LOTS of Money to CA Dems Including Gavin Newsom

The President of Glass House Farms, the cannabis farm that federal immigration authorities raided in California on Thursday despite protests, has donated thousands to Democrats in California.

Co-founder, president, and board director Graham Farrar, who self-identifies on social media as residing in Santa Barbara, California, has made numerous political donations to the Santa Barbara County Democratic Central Committee’s federal political action committee and Rep. Salud Carbajal, D-Calif., according to Federal Election Commission records.

According to California public campaign finance records, he also donated $10,000 to California Democratic Gov. Gavin Newsom in 2018, and his most recent public political donation was to California Democratic Assemblymember Gregg Hart in July 2023.

Incredible stuff.

While Gavin Newsom pretends to be righteously indignant about these raids, he’s really just mad one of his campaign donors got busted.

Keep reading

El Salvador Recalls Ambassador To Mexico Over Drug Plane Allegations

Salvadoran President Nayib Bukele said on July 9 that he was recalling El Salvador’s ambassador to Mexico for consultations after Mexico’s security chief claimed that a plane allegedly carrying cocaine had originated in El Salvador.

In a social media post, Bukele called the accusation false and urged Mexico to clarify and correct comments by Security Minister Omar Garcia Harfuch, who said during a press conference that the July 3 flight had come from El Salvador before it was intercepted in Colima, Mexico.

Bukele shared an image of the flight path and said tracking data showed the plane never entered Salvadoran airspace.

The president said Costa Rica reported a suspicious radar trace northwest of its territory on July 3.

“It was Costa Rica that activated the regional alert through APAN, a Central American air security network,” Bukele said.

“According to its own report, the aircraft’s trace entered Costa Rican airspace, briefly disappeared from radar, and then reappeared as it exited toward the Pacific. Our radars did not register any aerial contact within our airspace … Their report is clear: the aircraft flew over the Pacific Ocean and never entered Salvadoran territory.”

Bukele also criticized the Mexican government for not making public that three Mexican men were arrested over the flight.

“El Salvador does not shield criminals nor tolerate drug trafficking. We didn’t before, and we won’t now,” he said. “Nor will we allow attempts to involve us in operations that are neither our responsibility nor within our jurisdiction.”

Mexican authorities previously said three people were onboard the flight. They were arrested in Colima after 940 lb (427 kg) of cocaine was allegedly seized from the plane after landing.

Within hours of the post, Garcia Harfuch responded to Bukele on the social media platform X, saying that Mexican authorities first detected the plane about 200 km (120 miles) south of San Salvador, after which it ordered the military to intercept the suspicious flight. The map he posted also showed the plane’s route, although incomplete, over the Pacific Ocean.

Garcia Harfuch acknowledged that the men were Mexican and said they were facing criminal charges.

“We reiterate our respect and appreciation for the people of El Salvador,” he added.

Keep reading

7 Chinese nationals charged in MASSIVE money laundering, human smuggling, drug trafficking operation

Seven Chinese nationals have been charged in connection to a conspiracy to cultivate as well as distribute marijuana in the Northeastern United States. They undertook this operation by using a network of single-family houses in Massachusetts as well as Maine, according to the Department of Justice (DOJ).  

A press release from the DOJ on the charges stated that Jianxiong Chen, 39; Yuxiong Wu, 36; Dinghui Li, 38; Dechao Ma, 35; Peng Lian Zhu, 35; Hongbin Wu, 35; and Yanrong Zhu, 47 were all charged in connection to the network distributing the drugs around the Northeast. Six of the defendants were taken into custody earlier this week, with Yanrong Zhu still on the run as a fugitive.  

Most of the Chinese nationals have been charged with money laundering as well as conspiracy, and some were also charged with bringing assisting with bringing foreign nationals to the US illegally.

US Attorney Leah B. Foley said of the charges, “This case pulls back the curtain on a sprawling criminal enterprise that exploited our immigration system and our communities for personal gain. These defendants allegedly turned quiet homes across the Northeast into hubs for a criminal enterprise – building a multi-million-dollar black-market operation off the backs of an illegal workforce and using our neighborhoods as cover. That ends today.” 

The DOJ further stated, “According to the charging documents, from in or about January 2020, the defendants allegedly owned, operated or partnered with a network of interconnected grow houses in Massachusetts and Maine to cultivate and distribute kilogram-sized quantities of marijuana in bulk. Specifically, the enterprise allegedly operated grow houses in Braintree, Mass.; Melrose, Mass.; and Greenfield, Mass., among other locations in Massachusetts, Maine and elsewhere.” 

Keep reading

Newsom Protests ICE Raid on Marijuana Farm Allegedly Found Using Child Labor

California Gov. Gavin Newsom protested against an Immigration and Customs Enforcement (ICE) raid on a marijuana farm in his state this week that was allegedly found to have been using child labor.

Newsom reposted a video of the raid, calling President Donald Trump the “real scum” for enforcing the law.

U.S. Customs and Border Protection Commissioner Rodney Scott alleged that the farm had been found employing not only illegal aliens, but also “juveniles.”

Newsom was, in effect, trying to protect child labor.

The governor returned Thursday from a two-day swing to South Carolina, where he is testing the waters for a presidential run in three years’ time by introducing himself to voters in rural counties.

Keep reading

Psychedelic Drug May Slow Aging

Could magic mushrooms hold the key to slowing down aging? New research from Georgia’s Emory University suggests they just might.

A new study has found that psilocin—a compound produced in the body after consuming psilocybin, the active ingredient in psychedelic mushrooms—extended the lifespan of human skin and lung cells in the lab by more than 50 percent.

The researchers also found that mice treated with psilocybin lived 30 percent longer—not to mention more healthily—than their peers.

“This study provides strong preclinical evidence that psilocybin may contribute to healthier aging—not just a longer lifespan, but a better quality of life in later years,” Dr. Ali John Zarrabi, Director of Psychedelic Research at Emory University’s Department of Psychiatry said in a statement.

“As a palliative care physician-scientist, one of my biggest concerns is prolonging life at the cost of dignity and function. But these mice weren’t just surviving longer—they experienced better aging,” added Zarrabi, who co-led the study.

As part of their study, the researchers ran the first long-term assessment of psilocybin’s systemic effects in living animals.

They treated aged, 19-month-old mice—which is something like 60–65 in human years—with an initially low psilocybin dose of 5 mg, followed by a high dose of 15 mg every month for 10 months.

The team found that psilocybin-treated mice survived around 30 percent longer than their untreated peers. Moreover, the treated mice also looked healthier for it, with better fur quality, fewer white hairs and even hair regrowth.

While psilocybin is usually studied for its mental health benefits, the findings suggest that the compound may also tackle key drivers of aging.

According to the team, the psilocybin treatments reduced oxidative stress, improved the cells’ ability to repair DNA and helped preserve the length of telomeres—the protective caps on chromosomes that guard against damage leading to diseases like cancer, neurodegeneration and heart disease.

“Most cells in the body express serotonin receptors, and this study opens a new frontier for how psilocybin could influence systemic aging processes, particularly when administered later in life,” said senior author and former Emory professor Louise Hecker in a statement.

Though psilocybin may be best known for its hallucinogenic effects on the brain, most cells in the body have serotonin receptors, suggesting it could have much wider impacts.

Keep reading

Bipartisan Senators Agree To Delay Planned Federal Hemp Product Ban For One Year

A powerful Senate committee has approved a bill that contains provisions hemp industry stakeholders say would devastate the market by banning consumable hemp products with any “quantifiable” amount of THC. However, bipartisan members agreed to delay the implementation of the ban for one year.

On Thursday, the Senate Appropriations Committee passed Agriculture, Rural Development, FDA spending legislation that covers the next fiscal year—and also includes provisions that would significantly revise hemp laws following the crop’s legalization under the 2018 Farm Bill.

The bill “closes the hemp loophole that has resulted in the proliferation of unregulated intoxicating hemp products being sold across the country,” a committee summary says.

Ahead of the panel vote, several sources told Marijuana Moment that Sen. Mitch McConnell (R-KY), who championed hemp legalization through that 2018 legislation while serving as majority leader, was behind the restrictive cannabis language, vying to redefine his legacy by recriminalizing intoxicating cannabinoid products such as delta-8 THC.

At Thursday’s hearing, Sen. Jeff Merkley (D-OR) said he appreciates McConnell’s concerns but worries that the new prohibition would be overbroad and impact even non-intoxicating products, saying the language “addresses one very important issue, but causes another problem.”

“It’s been a privilege to work with Senator McConnell on hemp,” he said. “We first brought to this committee the idea that research should be done on hemp, and then later we put in an amendment that proceeded to allow seeds to be transferred across states, and now there is a hemp industry.”

“The important issue it addresses is not allowing hemp to be grown to produce hallucinogenic products, and that, unfortunately, due to the magic of laboratories, has occurred,” Merkley said. “But then there are other products that come from hemp such as CBD that has, in fact, been a significant factor as a healthcare supplement in many, many products across America that does not have a hallucinogenic effect.”

“I would like to continue to work with Senator McConnell to see if we can develop, in the course of this year, a definition that addresses hallucinogenic factors but does not eliminate the CBD product that is non hallucinogenic [and] that is valued by many Americans across the land,” he said.

“I know that there’s important work to be done on the hemp, but this one year [delay] will enable our farmers who are growing hemp currently to produce this year’s crop within the existing framework, and we’ll have a conversation over the coming year,” Merkley said.

McConnell appeared less interested in using the year to establish an alternative regulatory framework, saying that he’s simply agreeing to “give our hemp farmers ample time to prepare for their future.”

“The 2018 Farm Bill federally legalized hemp as an agricultural product,” the senator said. “This language had an unintended consequence that has allowed for intoxicating hemp-derived synthetic products to be made and sold across our country.”

“These intoxicating products have flooded the market in the absence—no regulatory structure, and [businesses] often use deceptive and predatory marketing towards children with packaging and logos similar to existing food products such as Oreos, candy, gummies and cereals,” McConnell said.

“The way I see it, the language I helped secure takes us back to the original intent of the 2018 Farm Bill, and closes this loophole,” the former Senate majority leader said, adding that the hemp provisions prior agriculture legislation “sought to create an agricultural hemp industry—not open the door to the sale of unregulated, intoxicating lab-made, hemp-derived substances with no safety framework.”

The hemp language in the new Senate spending bill is nearly identical to what the House Appropriations Committee passed late last month, with noted cannabis prohibitionist Rep. Andy Harris (R-MD) leading the charge.

Keep reading

Medical Marijuana Reduces Anxiety And Depression, New Federally Funded Study Shows

Medical marijuana was associated with “significant decreases in self-reported anxiety and depression” compared to before patients began treatment with cannabis, according to a new study funded in part by the National Institute on Drug Abuse (NIDA).

The observational study, published this month in the Journal of Affective Disorders, looked at 33 adults in Maryland with “clinically significant” anxiety and/or depression over a six-month period, evaluating them at baseline, and then again after one, three and six months from when patients began using medical cannabis.

“Significant decreases from baseline in anxiety and depression were observed, with mean scores dropping below clinically significant levels within three months of initiation,” the study says. Participants also reported sustained reductions in anxiety and/or depression symptoms over the six-month study period.

Most patients chose THC-dominant cannabis products. In addition to self-reported benefits to mental health, they also reported a decline in their perceived driving ability and an increase in feeling high.

“Acute effects were dose-dependent,” authors wrote: “10–15 mg of oral THC and at least 3 puffs of vaporized cannabis yielded the most robust reductions in anxiety and depression.”

Among participants, three-quarters said they had previously used marijuana. Just over a third (37 percent) said they’d used cannabis within the past year.

At the time of the study, medical marijuana was legal in Maryland but the substance remained illegal for nonmedical use.

The six-person team behind the new study represents the Johns Hopkins University School of Medicine, the Johns Hopkins School of Public Health and the university’s Sidney Kimmel Comprehensive Cancer Center, as well as the Centre for Alcohol Policy Research in Melbourne, Australia.

A conflict of interest section of the report notes that some members have received funding or currently work for companies involved in medical marijuana.

In addition to NIDA funding, the project also received support a pilot grant from the Lambert Center for the Study of Medicinal Cannabis and Hemp at Thomas Jefferson University.

Authors said that while the findings of the new study were promising, “controlled clinical trials are needed to further investigate the efficacy and safety of medicinal cannabis for acute anxiety and depression symptom management.”

Keep reading